🇺🇸 FDA
Patent

US 8012730

Specific lysis of staphylococcal pathogens by bacteriophage phi11 endolysin

granted A61KA61K38/00A61P

Quick answer

US patent 8012730 (Specific lysis of staphylococcal pathogens by bacteriophage phi11 endolysin) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary of Agriculture
Grant date
Tue Sep 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K38/00, A61P, A61P29/00, A61P31/04